index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Adolescence Mass cytometry Male Aldostérone Skeletal muscle Antisynthetase Anti-agalsidase antibodies Prognosis Deep immune profiling Interferon B cell homeostasis Abnormal movement CD8+T cells Female Acid-alpha-glucosidase Aldosterone Analyses multidimensionnelles Auto-immunité Adeno-associated virus Anti-MDA5 autoantibodies Autoimmune diseases Humans Assisted communication devices Data integration Myositis and muscle disease AAV vector Agalsidase Interstitial lung disease Antibodies Auto‐antibodies Biomarkers Antiphospholipid syndrome Inborn errors of metabolism Sphingosine-1-phosphate Autoantibodies Multidisciplinarity Autoimmunity Auto-antibodies Polymyositis Immunotherapy Anti-Mi2 IMNM CD8+ T-bet+ cells Inclusion body myositis Adeno-associated vector Myositis Anémie hémolytique Dermatomyositis Immune checkpoint inhibitors Anti-interleukin-6 Anti‐mitochondrial antibodies Cytokines Bioelectrical impedance analysis Muscle Gene therapy Antibody responses Adeno-associated virus vector COVID-19 AAV humoral immunity Biopsy Myocarditis AAV vectors IBM Antisynthetase syndrome Anti-synthetase syndrome Middle Aged AAV Adult Inflammatory myopathy Anti-drug antibodies Autoantibody Biomarqueurs B-lymphocyte Myopathy DM Systems biology Aged Acute Kidney Injury/epidemiology/etiology Adjudication Machine learning Antisynthétase Idiopathic inflammatory myopathies Anticorps anti-agalsidase Biomarker Outcome measures Anticorps spécifique des myosites AAV antibody Arthritis Fabry disease Lysosomal storage diseases Inflammation Adverse drug reactions Animals Cancer Dependovirus/genetics/immunology Amyotrophy Active Amyotrophic lateral sclerosis Case reports Anti-IgE IgG